Instructions for Vasilip (Simvastatin) 28 pills 20 mg
English product name
Vasilip
Release form
tab. film sheath, 20 mg: 14 or 28 pcs.
Description
The tablets, covered with a film shell of white or almost white color, are round, slightly double-convex, with a chamfer.
1 tab.
simvastatin 20 mg
Auxiliary substances: lactose monohydrate, pregelatinized starch, hydroxyanizole butyl, anhydrous citric acid, ascorbic acid, cornstarch, microcrystalline cellulose, magnesium stearate.
The film sheath consists of hypromellose, talc, propylene glycol and titanium dioxide.
7 pcs. - blister packs (2) - cardboard packs.
7 pcs. - blister packs (4) - cardboard packs.
ATC codes
C10AA01 Simvastatin
Clinical-pharmacological groups / Group affiliation Vasilip
Hypolipidemic drug
Active substance
simvastatin
Pharmacotherapy group Vasilip
Hypolipidemic agent - reductase inhibitor GMG-CoA
Pharmacological effect Vasilip
A hypolipidemic agent of the statins group, inhibitor of GMG-CoA reductase. It is a prodrug because it has a closed lactone ring in its structure, which is hydrolysed after entering the body.
Testimony Vasilip
- Primary hypercholesterolaemia in the ineffectiveness of diet therapy,
- combined hypercholesterolaemia and hypertriglyceridemia.
Method of use, course and dosage Simvastatin
Individual. The initial dose is five to twenty mg. If necessary, the dose is increased at intervals of four weeks. Simvastatin is taken once a day, in the evening. The maximum dose is forty mg per day.
For immunosuppressive patients, the recommended initial dose is five mg per day; the maximum dose is five mg per day
For severe renal failure (QC less than 30 ml/min), the initial dose is five to ten mg/day.
Use in children
The safety and effectiveness of the use of simvastatin in pediatric practice is not established. Not recommended for children.
- Nosology Vasilip (ICD codes)
- E78.0
- Pure hypercholesterolemia
- E78.2
- Mixed hyperlipidemia
